Biodesix, Inc. Files 8-K on Shareholder Votes and Financials
Ticker: BDSX · Form: 8-K · Filed: May 21, 2025 · CIK: 1439725
| Field | Detail |
|---|---|
| Company | Biodesix Inc (BDSX) |
| Form Type | 8-K |
| Filed Date | May 21, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, financial-reporting
TL;DR
Biodesix filed an 8-K covering shareholder votes and financials as of May 20, 2025.
AI Summary
Biodesix, Inc. filed an 8-K on May 21, 2025, reporting on matters submitted to a vote of security holders and financial statements. The filing pertains to events on May 20, 2025, and includes information about the company's incorporation in Delaware and its principal executive office located at 919 West Dillon Road, Louisville, Colorado.
Why It Matters
This filing provides updates on corporate governance and financial reporting for Biodesix, Inc., which is important for investors to understand the company's operational status and decisions.
Risk Assessment
Risk Level: low — This is a routine filing reporting on corporate actions and financial statements, not indicating any immediate material adverse events.
Key Players & Entities
- BIODESIX INC (company) — Registrant
- May 20, 2025 (date) — Date of earliest event reported
- May 21, 2025 (date) — Date of Report
- 919 West Dillon Road, Louisville, Colorado 80027 (location) — Principal Executive Office
FAQ
What is the primary purpose of this 8-K filing for Biodesix, Inc.?
The primary purpose is to report on Submission of Matters to a Vote of Security Holders and Financial Statements and Exhibits, as of May 20, 2025.
When was the earliest event reported in this filing?
The earliest event reported was on May 20, 2025.
What is the exact address of Biodesix, Inc.'s principal executive office?
The principal executive office is located at 919 West Dillon Rd., Louisville, Colorado 80027.
In which state was Biodesix, Inc. incorporated?
Biodesix, Inc. was incorporated in Delaware.
What is the SEC file number for Biodesix, Inc.?
The SEC file number for Biodesix, Inc. is 001-39659.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 21, 2025 regarding BIODESIX INC (BDSX).